Shopping Cart
Remove All
Your shopping cart is currently empty
Lanadelumab
😃Good
Catalog No. T76710Cas No. 1426055-14-2
Alias SHP-643, SHP643, DX-2930, DX2930
Lanadelumab (SHP643) is a humanized IgG1 monoclonal antibody targeting plasma kallikrein (pKal) with a Ki value of 0.12 nM. Lanadelumab effectively inhibits both free pKal and its interaction with high molecular weight kininogen (HMWK)-bound pKal. Lanadelumab has demonstrated potential in hereditary angioedema research and represents a promising therapeutic antibody for studying kallikrein-kinin system regulation.
Lanadelumab
Lanadelumab
😃Good
Purity: 95%
Catalog No. T76710Alias SHP-643, SHP643, DX-2930, DX2930Cas No. 1426055-14-2
Lanadelumab (SHP643) is a humanized IgG1 monoclonal antibody targeting plasma kallikrein (pKal) with a Ki value of 0.12 nM. Lanadelumab effectively inhibits both free pKal and its interaction with high molecular weight kininogen (HMWK)-bound pKal. Lanadelumab has demonstrated potential in hereditary angioedema research and represents a promising therapeutic antibody for studying kallikrein-kinin system regulation.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $647 | - | In Stock | |
| 10 mg | $987 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:97.4% (SDS-PAGE); 99.2% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Lanadelumab (SHP643) is a humanized IgG1 monoclonal antibody targeting plasma kallikrein (pKal) with a Ki value of 0.12 nM. Lanadelumab effectively inhibits both free pKal and its interaction with high molecular weight kininogen (HMWK)-bound pKal. Lanadelumab has demonstrated potential in hereditary angioedema research and represents a promising therapeutic antibody for studying kallikrein-kinin system regulation. |
| Targets&IC50 | pKal:0.12 nM (Ki) |
| In vitro | Lanadelumab (0-1000 nM) inhibits the proteolytic activity of pKal toward its endogenous substrate, single-chain HMWK. Furthermore, in vitro studies demonstrate that Lanadelumab potently prevents HMWK proteolysis and the subsequent release of bradykinin, with an IC50 of 1.3 nM.[2] |
| In vivo | Lanadelumab (20 mg/kg; i.v. or s.c.) exhibits an extended half-life of approximately 12.5 days and effectively blocks high molecular weight kininogen proteolysis in activated plasma in a dose- and time-dependent manner in cynomolgus monkeys. Additionally, Lanadelumab (1, 30 mg/kg; s.c.) significantly inhibits carrageenan-induced paw edema in male Sprague-Dawley rats.[2] |
| Synonyms | SHP-643, SHP643, DX-2930, DX2930 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | KLKB1/Plasma Kallikrein |
| Molecular Weight | 145.70 kDa |
| Cas No. | 1426055-14-2 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Lanadelumab | purchase Lanadelumab | Lanadelumab cost | order Lanadelumab | Lanadelumab in vivo | Lanadelumab in vitro | Lanadelumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.